ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value ($000): $421,815 (100.0% shares, 0.0% debt)

Holdings (67)

XBI SPDR SERIES TRUST 12.0%
Value ($000) $50,618 Shares 730,000 Est. Cost Unrealized
IWM ISHARES TR 9.5%
Value ($000) $39,869 Shares 290,000 Est. Cost Unrealized
VCYT VERACYTE INC 6.7%
Value ($000) $28,307 Shares 3,083,559 Est. Cost $7.18 Unrealized +13.9%
ASSEMBLY BIOSCIENCES INC 6.6%
Value ($000) $28,039 Shares 1,100,000 Est. Cost $11.90 Unrealized
LION BIOTECHNOLOGIES INC 6.0%
Value ($000) $25,442 Shares 3,415,044 Est. Cost $7.90 Unrealized
IRIX IRIDEX CORP 4.8%
Value ($000) $20,082 Shares 1,691,865 Est. Cost $11.81 Unrealized +19.0%
ACAD ACADIA PHARMACEUTICALS INC 4.7%
Value ($000) $19,691 Shares 572,756 Est. Cost $33.46 Unrealized +5.5%
ASND ASCENDIS PHARMA A S 3.7%
Value ($000) $15,400 Shares 550,000 Est. Cost $18.67 Unrealized
EDGE THERAPEUTICS INC 2.9%
Value ($000) $12,312 Shares 1,351,516 Est. Cost $10.63 Unrealized
NEURODERM LTD 2.8%
Value ($000) $11,948 Shares 450,000 Est. Cost $17.76 Unrealized
WEBMD HEALTH CORP 2.4%
Value ($000) $10,009 Shares 190,000 Est. Cost $51.92 Unrealized
NABRIVA THERAPEUTICS AG 1.9%
Value ($000) $8,133 Shares 677,710 Est. Cost $8.67 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 1.8%
Value ($000) $7,731 Shares 920,310 Est. Cost $6.47 Unrealized +7.5%
ACAD ACADIA PHARMACEUTICALS INC 1.7%
Value ($000) $7,220 Shares 210,000 Est. Cost $33.46 Unrealized +5.5%
VIVEVE MED INC 1.7%
Value ($000) $7,216 Shares 1,140,000 Est. Cost $6.33 Unrealized
CAS MED SYS INC 1.5%
Value ($000) $6,413 Shares 4,422,500 Est. Cost $1.52 Unrealized
CHEMBIO DIAGNOSTICS INC 1.5%
Value ($000) $6,371 Shares 1,202,144 Est. Cost $7.13 Unrealized
OXFORD IMMUNOTEC GLOBAL PLC 1.4%
Value ($000) $5,981 Shares 386,100 Est. Cost $12.00 Unrealized
ACRS ACLARIS THERAPEUTICS INC 1.4%
Value ($000) $5,964 Shares 200,000 Est. Cost $25.50 Unrealized +13.1%
TESARO INC 1.3%
Value ($000) $5,385 Shares 35,000 Est. Cost $153.86 Unrealized
MARVELL TECHNOLOGY GROUP LTD 1.3%
Value ($000) $5,341 Shares 350,000 Est. Cost $11.51 Unrealized
RA PHARMACEUTICALS INC 1.3%
Value ($000) $5,279 Shares 247,956 Est. Cost $15.19 Unrealized
DBV TECHNOLOGIES S A 1.2%
Value ($000) $5,272 Shares 149,690 Est. Cost $35.62 Unrealized
ASSEMBLY BIOSCIENCES INC 1.2%
Value ($000) $5,098 Shares 200,000 Est. Cost $11.90 Unrealized
JNJ JOHNSON & JOHNSON 1.2%
Value ($000) $4,982 Shares 40,000 Est. Cost Unrealized
ZOGENIX INC 1.1%
Value ($000) $4,743 Shares 437,113 Est. Cost $10.85 Unrealized
VRAYQ VIEWRAY INC 1.1%
Value ($000) $4,637 Shares 601,073 Est. Cost $5.45 Unrealized 0.0%
AVEXIS INC 1.0%
Value ($000) $4,258 Shares 56,000 Est. Cost $76.04 Unrealized
ANAB ANAPTYSBIO INC 1.0%
Value ($000) $4,138 Shares 165,690 Est. Cost $23.32 Unrealized 0.0%
NEURODERM LTD 0.9%
Value ($000) $3,983 Shares 150,000 Est. Cost $17.76 Unrealized
MEDICINES CO 0.8%
Value ($000) $3,423 Shares 70,000 Est. Cost $48.90 Unrealized
EVH EVOLENT HEALTH INC 0.8%
Value ($000) $3,345 Shares 150,000 Est. Cost $19.20 Unrealized 0.0%
NANOSTRING TECHNOLOGIES INC 0.8%
Value ($000) $3,277 Shares 164,932 Est. Cost $19.87 Unrealized
IMMUNOMEDICS INC 0.8%
Value ($000) $3,254 Shares 503,000 Est. Cost $2.70 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 0.7%
Value ($000) $2,936 Shares 400,000 Est. Cost $3.22 Unrealized +43.6%
BCRX BIOCRYST PHARMACEUTICALS 0.6%
Value ($000) $2,730 Shares 325,000 Est. Cost $6.47 Unrealized +7.5%
CLOVIS ONCOLOGY INC 0.6%
Value ($000) $2,570 Shares 40,361 Est. Cost $63.68 Unrealized
CORBUS PHARMACEUTICALS HLDGS 0.6%
Value ($000) $2,393 Shares 290,000 Est. Cost Unrealized
MARVELL TECHNOLOGY GROUP LTD 0.5%
Value ($000) $2,251 Shares 147,500 Est. Cost $11.51 Unrealized
ESSA PHARMA INC 0.4%
Value ($000) $1,876 Shares 605,300 Est. Cost $4.68 Unrealized
NEKTAR THERAPEUTICS 0.4%
Value ($000) $1,798 Shares 76,600 Est. Cost Unrealized
EVH EVOLENT HEALTH INC 0.4%
Value ($000) $1,784 Shares 80,000 Est. Cost $19.20 Unrealized 0.0%
SAGE THERAPEUTICS INC 0.3%
Value ($000) $1,421 Shares 20,000 Est. Cost Unrealized
PROGENICS PHARMACEUTICALS IN 0.3%
Value ($000) $1,416 Shares 150,000 Est. Cost $9.44 Unrealized
CLEARSIDE BIOMEDICAL INC 0.3%
Value ($000) $1,390 Shares 175,000 Est. Cost $8.94 Unrealized
ALIMERA SCIENCES INC 0.3%
Value ($000) $1,364 Shares 974,318 Est. Cost $5.54 Unrealized
SYNERON MEDICAL LTD 0.3%
Value ($000) $1,291 Shares 122,400 Est. Cost $10.55 Unrealized
VCYT VERACYTE INC 0.3%
Value ($000) $1,193 Shares 130,000 Est. Cost $7.18 Unrealized +13.9%
ZOGENIX INC 0.3%
Value ($000) $1,085 Shares 100,000 Est. Cost $10.85 Unrealized
ARRAY BIOPHARMA INC 0.3%
Value ($000) $1,077 Shares 120,500 Est. Cost Unrealized
DBV TECHNOLOGIES S A 0.3%
Value ($000) $1,057 Shares 30,000 Est. Cost $35.62 Unrealized
VERSARTIS INC 0.2%
Value ($000) $1,048 Shares 49,100 Est. Cost Unrealized
ADVISORY BRD CO 0.2%
Value ($000) $997 Shares 21,300 Est. Cost $46.81 Unrealized
XBIT XBIOTECH INC 0.2%
Value ($000) $989 Shares 60,000 Est. Cost Unrealized
PROGENICS PHARMACEUTICALS IN 0.2%
Value ($000) $944 Shares 100,000 Est. Cost $9.44 Unrealized
ROCKWELL MED INC 0.2%
Value ($000) $876 Shares 140,000 Est. Cost Unrealized
CONCERT PHARMACEUTICALS INC 0.2%
Value ($000) $837 Shares 49,051 Est. Cost $17.06 Unrealized
INVITAE CORP 0.2%
Value ($000) $774 Shares 70,000 Est. Cost Unrealized
AEHR AEHR TEST SYSTEMS 0.1%
Value ($000) $587 Shares 122,000 Est. Cost $3.76 Unrealized 0.0%
INVITAE CORP 0.1%
Value ($000) $553 Shares 50,000 Est. Cost Unrealized
OMER OMEROS CORP 0.1%
Value ($000) $454 Shares 30,000 Est. Cost Unrealized
XBIT XBIOTECH INC 0.1%
Value ($000) $330 Shares 20,000 Est. Cost Unrealized
LION BIOTECHNOLOGIES INC 0.1%
Value ($000) $298 Shares 40,000 Est. Cost $7.90 Unrealized
QUOTIENT LTD 0.0%
Value ($000) $132 Shares 18,900 Est. Cost $6.98 Unrealized
ONCOBIOLOGICS INC 0.0%
Value ($000) $78 Shares 29,082 Est. Cost $3.40 Unrealized
ONCOBIOLOGICS INC 0.0%
Value ($000) $77 Shares 96,833 Est. Cost $0.46 Unrealized
ONCOBIOLOGICS INC 0.0%
Value ($000) $48 Shares 96,833 Est. Cost $0.45 Unrealized